skip to content

Cooperation with Boehringer Ingelheim

Success through tradition and innovation
Improving the health and quality of life of humans and animals is the goal of the research-based pharmaceutical company Boehringer Ingelheim. The focus is on diseases for which there is as yet no satisfactory treatment option. The company concentrates on developing innovative therapies that can prolong the lives of patients. In animal health, Boehringer Ingelheim stands for advanced prevention.

Since its foundation in 1885 as a family-owned company, Boehringer Ingelheim is today among the top 20 companies in the industry. For the three business areas Human Pharmaceuticals, Animal Health and Biopharmaceuticals, around 50,000 employees create value through innovation every day.

Further information at: